Fantastic achievement by BIO and another clinically proven product to their range! It's hard to find many companies this size with such a broad range of products. In my view it plays a big role in de-risking sales growth and they appear to be on track to beat the analysis sales forecasts so this will only further the potential upside.
Well done to the Bio Team!
Ann: Clinical trial on asthma sufferers validates Biome probiotic, page-4
Add BIO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.005(1.35%) |
Mkt cap ! $79.81M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 37.5¢ | 37.0¢ | $89.07K | 238.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25000 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 64204 | 3 |
View Market Depth
| Last trade - 15.01pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
37.0¢ |
Change
0.005 ( 0.11 %) |
||||
| Open | High | Low | Volume | ||
| 37.5¢ | 38.0¢ | 36.5¢ | 86883 | ||
| Last updated 13.51pm 17/06/2024 ? | |||||
| BIO (ASX) Chart |
